Julien Isoard
Bioprocessing Market Manager, Novasep
After an engineer school in biotechnology, I made up my mind to complete my curriculum with a business degree.
Involved in quality control, process development, tech transfer & marketing research during my intern trainees, I took a position as Business developer in biomanufacturing field.
Particularly fond of cinema, litterature and advertising, with a taste for transversal view, I'd be also pleased to progress into a position in communication in the future.
MBTI profiling : ENTJ
133 contacts> International representation and B2B meetings
> Contract agreement writing and negotiation
> Projects follow-up with respect to resources allocation and potential business impacts
> International sales force training
> Turn-over consolidation & forecast
> Corporate website writing & marketing tools
Novasep brings innovative solutions to complex challenges within the life science industries for the production of synthetic molecules and biomolecules.
In order to fulfill our customers’ ingredient needs, we develop and use a broad portfolio of technologies to support our unique business model:
• we develop manufacturing solutions,
• we provide custom manufacturing services (outsourcing solutions),
• we sell purification processes (in-sourcing solutions).
Our offering helps our customers to enhance product quality, reduce production costs and shorten time-to-market.
Novasep Process, cGMP subsidiary of Novasep group, provides turn-key packages from early development to commercial manufacturing services for API & HP-API.
> Biopharma strategy
> Market trends analysis
> Price policy establishment
2008 - 2010HENOGEN S.A. is a cGMP BL2/BL3 multi-purpose Contract Manufacturing Organization ables to produce biologics through every expression system up to 1,000L scale from gene to clinical product phase III, including process flow-chart development, up-scale, potency assays, virus clearance scale-down study, QC method validation, F&F&F and final QP release.
Henogen has a 10 years expertise in biopharmaceutical field with more than 170 projects including ;
- virus vaccines (HSV, HIV, VZV, VSV, RSV, Influenza, HPV, MLV,...),
- gene therapy (EIAV,..),
- attenuated strains (Pertussis, Sonnei, Flexneri, Cholera,..),
- monoclonal antibodies (anti-CD20, anti-CD28, anti-CD7, anti-CD3, anti-rhesusD, Hvv, ScFv),
- recombinant proteins (LSA3, MSP1, MSP3, HLA, EPO,..),
- dozens of MCB-WCB (E.Coli, L.lactis, CHO, MRC-5, Vero, HEK, BHK, NIH/3T3, NS0, YB2/0,…) and MVSS-DVSS
- cytokines (GM-CSF, IL,TNF,INF,..)
To be counted among our partners, Wyeth/Pfizer, GlaxoSmithKline, Oxford Biomedica, AVIR Green Hills Biotech, Pasteur, LFB,...
Thesis: “Impacts of single-use bioreactor implementation on Biomanufacturing market and Organizations”
2006 - 2007SFRI has accumulated and displayed, during its 25 years experience, a tremendous know how dedicated to haematology instruments and reagents. SFRI covers the whole spectrum of haematology needs : instruments, reagents, blood quality controls, spare parts, service and maintenance.
Julien has developed an ELISA kit for isoflavones measurement in various kind of matrix from food ingredients to nutraceutic compounds. He was also in charge of market studies challenging HPL chromatography method, evaluate potential incomes and keeping an eye on regulatory authorities development.
> Market research
> Technology transfer
> ELISA development and industrial customization
Thesis: “Marketing and development for immunology kits”
2005 - 2005BIOSENTEC is focused on the conception, the development, the manufacturing and the marketing of reagents, enzymatic kits for compounds measurement in agro-food and pharmaceutical environments.
Julien validated enzymatic kits through statistic tools certifying linearity, accuracy, detection limits, and all paramaters for analytical quality control method.
> Applied enzymology
> Quality validation via Biostatistics use
Thesis: "Development and CE certification for enzymatic kits"
